The MitraClip® has increasing use for severe, high surgical risk mitral regurgitation (MR). The MitraClip® is implanted percutaneously across the interatrial septum. Given the large diameter of the device delivery system, the femoral vein is the best option for central venous access. This is the first reported case of successful MitraClip® implantation through a chronically occluded IVC filter. © 2015 Wiley Periodicals, Inc.
Keywords: TTE/TEE; catheterization; imaging; interventional devices/innovation; mitral valve disease; percutaneous intervention; transseptal.
© 2015 Wiley Periodicals, Inc.